Science
Beyond the Weight Loss Revolution: New Drug Targets the Hidden Cost of Ozempic and Wegovy
A promising monoclonal antibody could prevent the significant muscle loss that accompanies GLP-1 weight loss injections, addressing one of the most pressing side effects of the obesity drug boom.
Redazione NotiziHub·June 8, 2026·9 min read